ClinicaliQ Podcasts
Three series covering the guidelines, drug classes, and practical prescribing topics that matter most to UK healthcare professionals.
Three Series. One Platform.
Every episode is produced with a practising pharmaceutical physician, grounded in current UK and European guidance.
In-depth discussions of the latest NICE, ESC, and other major clinical guidelines — unpacking what's changed and what it means for your practice.
Deep-dive episodes on the most clinically significant drug classes — mechanism of action, evidence base, patient selection, monitoring, and common pitfalls.
Short, practical episodes on everyday prescribing challenges — the bread-and-butter topics every clinician needs to get right, every time.
9 Episodes Available Now
Organised by series. Each episode earns CPD credit.
GLP-1 Agonists: Semaglutide, Tirzepatide and the Cardiovascular Revolution
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity. In this episode, Dr Anzal Qurbain explains how they work, the landmark cardiovascular trials that changed...
SGLT2 Inhibitors: From Glycaemia to Heart Failure and Chronic Kidney Disease
SGLT2 inhibitors started as diabetes drugs and became some of the most important medicines in cardiology and nephrology. Dr Anzal Qurbain covers the mechanism, the landmark DAPA-HF, EMPEROR-Reduced,...
JAK Inhibitors: Updated Safety Signals, Patient Selection and Post-ORAL Surveillance
JAK inhibitors have transformed inflammatory diseases from rheumatoid arthritis to eczema — but post-marketing safety data has reshaped how we use them. Dr Anzal Qurbain unpacks the updated...
Sick Day Rules: Which Medicines to Stop and When
This episode explains sick day rules — guidance for patients on certain chronic medications to pause their medicines during acute illness with dehydration, vomiting, diarrhoea, or high fever....
Monitoring Medicines: Blood Tests, Timing and What to Watch For
This episode covers monitoring requirements for high-risk medicines including lithium, methotrexate, clozapine, amiodarone, statins, ACE inhibitors, ARBs, warfarin, and direct oral anticoagulants. Dr Qurbain explains monitoring frequencies, what...
Prescribing in Pregnancy: Safe Choices, Teratogens and Risk Communication
This episode explores safe prescribing in pregnancy, addressing why evidence is limited due to exclusion of pregnant women from trials, and covering specific drug safety guidance. It discusses...
Polypharmacy and Deprescribing: When Less Is More
This episode explores polypharmacy (five or more regular medicines) and deprescribing strategies for UK healthcare professionals. It defines appropriate versus problematic polypharmacy, introduces the STOPP/START criteria as a...
Drug Interactions: Mechanisms, Red Flags and Practical Management
This episode covers the mechanisms and practical management of drug interactions in clinical practice, distinguishing between pharmacokinetic interactions (affecting drug absorption, metabolism, and excretion through CYP450 enzyme inhibition...